Tasneem Lalani to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Tasneem Lalani has written about Carcinoma, Hepatocellular.
Connection Strength
1.525
-
Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Hindman NM, Kaur H, McNamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria? Chronic Liver?Disease. J Am Coll Radiol. 2017 Nov; 14(11S):S391-S405.
Score: 0.485
-
Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Hindman NM, Kaur H, McNamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria? Chronic Liver?Disease. J Am Coll Radiol. 2017 May; 14(5S):S103-S117.
Score: 0.469
-
Ismail M, Lalani T, Kielar A, Hong C, Yacoub J, Lim C, Surabhi V, Shanbhogue K, Nandwana S, Liu X, Santillan C, Bashir MR, Lee J. Lessons learned: strategies for implementing and the ongoing use of LI-RADS in your practice. Abdom Radiol (NY). 2025 05; 50(5):2053-2065.
Score: 0.197
-
Kamal O, Haghshomar M, Yang J, Lalani T, Bijan B, Yaghmai V, Mendiratta-Lala M, Hong CW, Fowler KJ, Sirlin CB, Kambadakone A, Lee J, Borhani AA, Fung A. CT/MRI technical pitfalls for diagnosis and treatment response assessment using LI-RADS and how to optimize. Abdom Radiol (NY). 2025 05; 50(5):2022-2037.
Score: 0.197
-
Marks RM, Fung A, Cruite I, Blevins K, Lalani T, Horvat N, Protopapas Z, Chaudhry H, Bijan B, Shiehmorteza M, Nepal P, Tang A. The adoption of LI-RADS: a survey of non-academic radiologists. Abdom Radiol (NY). 2023 08; 48(8):2514-2524.
Score: 0.178